Bibliometrics analysis and knowledge mapping of pertussis vaccine research: trends from 1994 to 2023

Caixia Tan,Yuanyuan Xiao,Siyao Chen,Ting Liu,Juan Zhou,Sisi Zhang,Yiran Hu,Jingxiang Zhou,Zhongyan She,Biyue Tian,Anhua Wu,Chunhui Li
DOI: https://doi.org/10.1007/s15010-024-02414-7
2024-10-18
Infection
Abstract:Purpose This study aims to use bibliometric methods to explore the evolving landscape, hotspots, and emerging frontiers of pertussis vaccine research, providing deeper insights into the current research landscape and guiding future vaccine development efforts. Methods We conducted a comprehensive search of the Web of Science Core Collection database (WoSCC) from January 1, 1994, to December 31, 2023, employing search terms related to vaccination (vacc* or immun*) and pertussis (pertussis, Whooping Cough, Bordetella pertussis , B. pertussis , Bordetella pertussis infection, or B. pertussis infection) in the Title or Author keywords fields. Bibliometrics analysis of pertussis research was performed utilizing the bibliometrix-biblioshiny package in RStudio, alongside CiteSpace and VOSviewer software. Results In total, 2,623 records were analyzed, comprising 89.63% ( n = 2,351) original research articles and 10.37% ( n = 272) review articles. The study revealed that academic research on the pertussis vaccine was growing at a rate of 4.64% per year. The United States and Canada lead in the number of publications. GlaxoSmithKline and the Centers for Disease Control & Prevention– United States emerged as leading institutions, with Halperin SA and Locht C as the most active authors. Vaccine was the most influential journal. Most studies focused on vaccine effectiveness duration, vaccination schedules for high-risk groups, and people's attitudes toward vaccination. Conclusion Our analysis showed increasing interest of researchers in pertussis literature, yet current research mainly emphasized expanding vaccine coverage and optimizing strategies, neglecting new vaccine development. This emphasized the need for prioritizing novel pertussis vaccines to tackle the resurgence challenge.
infectious diseases
What problem does this paper attempt to address?